PlainRecalls
FDA Drug Moderate Class II Terminated

Zileuton Extended-Release Tablets, 600 mg, 120-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD 21202 by Lupin Limited, Nagpur-441108, India, NDC 68180-169-16

Reported: June 22, 2022 Initiated: June 10, 2022 #D-1150-2022

Product Description

Zileuton Extended-Release Tablets, 600 mg, 120-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD 21202 by Lupin Limited, Nagpur-441108, India, NDC 68180-169-16

Reason for Recall

Failed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.

Details

Units Affected
3,216 bottles
Distribution
Product was distributed to 10 wholesalers/distributors and one mail order account who may have further distributed the product nationwide.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Zileuton Extended-Release Tablets, 600 mg, 120-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD 21202 by Lupin Limited, Nagpur-441108, India, NDC 68180-169-16. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 3,216 bottles.
Why was this product recalled?
Failed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 22, 2022. Severity: Moderate. Recall number: D-1150-2022.